Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065225

SVP & General Counsel sold 6,564 shares at $13.16 ($86,382)

  • SVP & General Counsel acquired 20,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · SVP & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-15 Grant or award : show line 1 in the form +20,100 93,000 D
2021-11-16 Sale : show line 2 in the form −6,564 $13.16 $86,382 86,436 D
Open-market sales · 6,564 sh · avg $13.16 · $86,382
Loading xslF345X03/doc4.xml…